תכנית מדעית

Thursday 15th November, 2018

8:00- 9:00

Registration and Coffee

Congress opening and greetings
Session A
Chairs:  Dr. Malena Cohen-Cymberknoh, MD and Dr. Michal Shteinberg, MD, PhD
(Session conducted in English)

9:00- 9:10

 

Welcome and introduction

Malena Cohen-Cymberknoh, MD; CF Center, Hadassah Medical Center, Jerusalem

 

9:10- 9:25

 

Meconium ileus in CF-PS

Michael Wilschanski, MD; CF Center, Hadassah Medical Center, Jerusalem

9:25- 9:40

Nutritional status in childhood and lung function in adulthood

Moshe Ashkenazi, MD; The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer

9:40- 09:55

Correlation between Lung Clearance Index (LCI) and CF severity markers

Elad Ben Meir, MD; CF Center, Hadassah Medical Center, Jerusalem

9:55- 10:10

Six-minute walk test, LCI and QOL in CF and BO

Michal Gur, MD; CF Center Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa

10:10-10:25

The effect of inhaling a β2-agonist, prior to respiratory physiotherapy, on lung function of Cystic Fibrosis Subjects

Daphna Vilozni, PhD: The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer   

10:25- 10:40

Investigating CF in adult patients with bronchiectasis

Michal Shteinberg, MD, PhD; CF Center, Carmel Medical Center, Haifa &

Adi Dagan, MD; The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer

10:40-11:15

Coffee Break

Session B
Chairs: Dr. David Shoseyov, MD and Dr. Moshe Ashkenazi, MD
(Session conducted in English)

11:15-11:30

Long-term IV antibiotics using a peripheral line - is this possible?

Yulia Gendler, RN; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

11:30-11:45

Is there still a role for selected bronchoscopy in CF?

Alex Gileles-Hillel, MD; CF Center, Hadassah Medical Center, Jerusalem

11:45-12:00

Diagnostic value of sputum cultures in children under two years of age with chronic lung disease

Gal Zaks, MD; Graub CF Center, Schneider Children's Medical Center,

Petah Tikva

12:00-12:15

Identification and monitoring of early lung disease: how aggressive should we be?

Eitan Kerem, MD; CF Center, Hadassah Medical Center, Jerusalem

12:15-14:00

Lunch

Session C
Chairs: Dr. Huda Georgy Mussaffi, MD and Dr. Dario Prais, MD
(Session conducted in English)

 

14:00- 14:30

Special Lecture

CF- Past, present and future

Hannah Blau, MBBS; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

14:30- 14:50

New and future therapies for CF

Malena Cohen-Cymberknoh, MD; CF Center, Hadassah Medical Center, Jerusalem

14:50- 15:10

From double to triple combination CFTR modulators

Dario Prais, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

15:10- 15:30

Ivacaftor for patients with residual function mutations in Israel:Update on the VX16-770-127 study

Thea Pugatsch, PhD; CF Center, Hadassah Medical Center, Jerusalem

15:30- 16:00

Coffee Break and Exhibition

Session D
Chairs: Prof. Batsheva Kerem, PhD and Prof. Lea Bentur, MD
(Session conducted in English)

16:00- 16:20

Restoration of CFTR function by antisense oligonucleotide splicing modulation

Batsheva Kerem, PhD; Life Sciences Institute, Hebrew University, Jerusalem

 

16:20- 16:45

Developing CFTR modulators for rare and hard-to-treat mutations

Alan S. Verkman, MD, PhD; UCSF Medical Center, San Francisco, CA

16:45- 17:10

CFTR modulators as therapy for rare mutations

George Solomon, MD; UAB Hospital, Birmingham, Alabama

17:10- 17:40

Genetic modifiers as therapy for Cystic Fibrosis

Garry R Cutting, MD; The Johns Hopkins Hospital, Baltimore, Maryland

17:40- 18:00

The Q359K/T360K mutation causes CF in Georgian Jews
Meir Mei Zahav, MD; Graub CF Center, Schneider Children's Medical Center,

Petah Tikva & Hanoch Senderowitz, PhD; Dep. Chemistry, Bar Ilan University

Friday 16th November, 2018

08:15- 9:00

Registration

Session E
Chairs: Prof. Ori Efrati, MD and Dr. Ori Inbar, PhD
(Session conducted in English)

 

9:00- 9:20

The Israeli CF Registry Annual Data

Meir Mei Zahav, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

 

09:20- 9:50

What we did and didn’t learn from CFTR2

Garry R Cutting, M.D. The Johns Hopkins Hospital, Baltimore, Maryland

 

9:50- 10:20

 

Organoids as a tool to predict response to therapy – non-functional versus residual function CFTR

Kors van der Ent, M.D., UMC, Utrecht, The Netherland

10:20-10:40

Phage therapy, from sewage to the patient bed- The story of the first treatment in Israel

Ronen Hazan, PhD, Institute of Dental Sciences and School of Dental Medicine Hadassah-Hebrew University, Jerusalem

10:40 –11:00

Targeting bio-mineralization to combat antibiotic resistant Pseudomonas infections

Ilana Kolodkin-Gal, PhD; Dep. Molecular Genetics, Weizmann Institute, Rehovot

11:00-11:30

Coffee Break and Exhibition

Session F
Chairs: Dr. Inbal Golan-Tripto, MD and Dr. Michal Gur, MD
(Session conducted in English)

11:30 -11:45

Like mother, like daughter- 2 generations of CF

Karin Yaacoby-Bianu, MD; CF Center, Carmel Medical Center, Haifa

11:45- 12:00

Role of glucose and insulin area under the curve (AUC) in the management of CFRD

Silwan Miari, CF Center, Hadassah Medical Center, Jerusalem

12:00- 12:15

From hunger strike to a fun meal

Dana Serfaty, MPH RD, & Eddie Landau, PhD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

12:15-12:30

Stigma and disclosure in CF

Shifra Kurtz, MSW; CF Center, Hadassah Medical Center, Jerusalem  

12:30-12:45

Attention-deficit hyperactivity disorders (ADHD) in patients with CF

Tzlil Tanny; CF Center, Hadassah Medical Center, Jerusalem

12:45

Closing remarks

Malena Cohen-Cymberknoh, MD; CF Center, Hadassah Medical Center, Jerusalem

13:00

Lunch   

14:30

Professional group meetings:

CF Center physicians

CF Nurses and Research Coordinators

CF Dieticians

CF Physiotherapists 

CF Psychologists and social workers